Genentech Sues Dr. Reddy's Over Generic Valcyte

Law360, New York (December 21, 2011, 6:46 PM EST) -- Roche Holding Ltd. subsidiary Genentech Inc. hit Dr. Reddy's Laboratories Ltd. with a patent infringement suit in Delaware federal court on Tuesday, continuing its ongoing defense of the anti-viral drug Valcyte.

Genentech and Roche Palo Alto LLC allege Dr. Reddy's infringed U.S. Patent Number 6,083,953 by seeking U.S. Food and Drug Administration approval for a generic version of Valcyte. It seeks to block the Indian drugmaker from selling its generic in the U.S. before that patent expires.

Valcyte, the name under which Genentech markets tablets containing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.